MedPath

安徽瑞旗药业有限公司

Ownership
-
Established
2021-12-03
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Erdosteine Dispersible Tablets

Product Name
厄多司坦分散片
Approval Number
国药准字H20080771
Approval Date
Jun 26, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.